Eradicating hepatitis C virus ameliorates insulin resistance without change in adipose depots. (Q42225921)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24716635%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

title

Eradicating hepatitis C virus ameliorates insulin resistance without change in adipose depots (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24716635%20AND%20SRC:MED&resulttype=core&format=json

eradication of infectious diseases

13 March 2020

main subject

1 reference

1 reference

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24716635%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Michael I Trenell

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24716635%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Samocha-Bonet

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24716635%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

author name string

K-L Milner

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24716635%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

J Tid-Ang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24716635%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

M Weltman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24716635%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

A Xu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24716635%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

J George

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24716635%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

D J Chisholm

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24716635%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

publication date

12 August 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24716635%20AND%20SRC:MED&resulttype=core&format=json

Journal of Viral Hepatitis

13 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24716635%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24716635%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24716635%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

page(s)

325-332

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24716635%20AND%20SRC:MED&resulttype=core&format=json

Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3.

13 March 2020

cites work

1 reference

Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients.

21 January 2018

1 reference

Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected].

21 January 2018

1 reference

Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance.

21 January 2018

1 reference

Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis C.

21 January 2018

1 reference

Clearance of HCV improves insulin resistance, beta-cell function, and hepatic expression of insulin receptor substrate 1 and 2.

21 January 2018

1 reference

Changes in insulin sensitivity and body weight during and after peginterferon and ribavirin therapy for hepatitis C.

21 January 2018

1 reference

Eradication of hepatitis C virus by interferon improves whole-body insulin resistance and hyperinsulinaemia in patients with chronic hepatitis C.

21 January 2018

1 reference

Impact of insulin resistance on HCV treatment response and impact of HCV treatment on insulin sensitivity using direct measurements of insulin action

21 January 2018

1 reference

Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a probability index

21 January 2018

1 reference

Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model

21 January 2018

1 reference

Java-based graphical user interface for MRUI, a software package for quantitation of in vivo/medical magnetic resonance spectroscopy signals

21 January 2018

1 reference

Time-domain quantification of series of biomedical magnetic resonance spectroscopy signals.

21 January 2018

1 reference

An accurate and robust method for unsupervised assessment of abdominal fat by MRI.

21 January 2018

1 reference

Validity of a new automated software program for visceral adipose tissue estimation

21 January 2018

1 reference

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome.

21 January 2018

1 reference

Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans.

21 January 2018

1 reference

The type I interferon receptor mediates tyrosine phosphorylation of insulin receptor substrate 2

21 January 2018

1 reference

Weight loss during pegylated interferon and ribavirin treatment of chronic hepatitis C*.

21 January 2018

1 reference

Serum lipid pattern in chronic hepatitis C: histological and virological correlations

21 January 2018

1 reference

Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis

21 January 2018

1 reference

Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C.

21 January 2018

1 reference

Association between lipoprotein subfraction profile and the response to hepatitis C treatment in Japanese patients with genotype 1b.

21 January 2018

1 reference

Interferon-lambda genotype and low serum low-density lipoprotein cholesterol levels in patients with chronic hepatitis C infection.

21 January 2018

1 reference

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

21 January 2018

1 reference

Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease.

21 January 2018

1 reference

Insulin resistance and liver injury in hepatitis C is not associated with virus-specific changes in adipocytokines

21 January 2018

1 reference

Comparison of surrogate and direct measurement of insulin resistance in chronic hepatitis C virus infection: impact of obesity and ethnicity

21 January 2018

1 reference

Glucagon metabolism in normal subjects and in cirrhotic patients before and after portasystemic venous shunt surgery

21 January 2018

1 reference

Altered expression of glucagon-like peptide-1 and dipeptidyl peptidase IV in patients with HCV-related glucose intolerance

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JVH.12143

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24716635%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

1 reference